New York S 5352: Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product

Status: REFERRED TO HIGHER EDUCATION (as of 2026-01-07)

State: New York · Session: 2025-2026 · Bill: S 5352

Sponsors: Leroy Comrie

View New York S 5352 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.